S. J. Vermeersch, L. Clemensen, V. Clemensen, M. Nybo. Quantifying the added value of Abbott Architectinstrumentation, in conjuntion with AcceleratorLaboratory Automation system and process optimization. A case study in the Clinical Biomechemistry and Pharmacology lab ofthe the Odense University Hospital [Whitepaper]
Burnier M., Martin P.-Y., Binet I., Tsinalis D., Kistler T., Tanghe A., Demey J.Potential contribution of less frequently dosed erythropoiesis stimulating agents (ESA) to the operational efficiency of anaemia management: A study in 4 Swiss haemodialysis centres. 39th Annual Meeting Swiss Society of Nephrology, Lausanne, December 2007.
Fung E., Musing E., Tanghe A., Butaye K. Process Flow for Erythropoiesis Stimulating Agents (ESA) Delivery to Haemodialysis (HD) Patients at Toronto General Hospital - Process Optimization and Impact Analysis of Alternative Dosing Frequencies. Summer Educational Sessions Canadian Society of Hospital Pharmacists, Winnipeg, August 2009.
Burnier M., Teta D., Oudy C., Demey J., Tanghe A. Potential Contribution of Every Other Week Administered Erythropoiesis Stimulating Agents to the Operational Efficiency of Anemia Management in a Haemodialysis Center: an Explorative Pilot Study in a Haemodialysis Center in Switzerland. 38th Annual Meeting Swiss Society of Nephrology, Solothurn, December 2006.